Does Carfilzomib need to be taken for a year?

Treatment duration with Carfilzomib usually does not last a full year and is based on the patient's specific condition and treatment plan. The duration, frequency, and total dose of treatment cycles will vary based on the patient's condition, response to treatment, and physician recommendations.

1.Multiple Myeloma Treatment Plan: Carfilzomib is commonly used to treat multiple myeloma, a malignant blood cancer. Treating multiple myeloma often requires long-term management, including first-line therapy and treatment of relapses.

2.First-line treatment: For first-line treatment, that is, for patients who are first diagnosed with multiple myeloma, treatment will often include a combination of multiple drugs, of which carfilzomib may be one of them. Cycles of first-line treatment typically last several months rather than a full year. Patients may need to receive carfilzomib injections weekly or every two weeks, but the exact dosage and frequency will vary based on individual circumstances.

3.Relapse Treatment: Carfilzomib may also be an effective treatment option for those patients whose disease relapses or becomes resistant to first-line therapy. Relapse treatment is usually an ongoing management process, and patients may receive several cycles of treatment with some downtime between each cycle. The time frame for treatment will vary based on response to treatment and disease control.

4.Individualized treatment: The treatment plan for carfilzomib is highly individualized. Doctors will determine the most appropriate treatment plan based on the patient's condition, weight, age and health status. This means treatment times may vary from patient to patient.

Carfilzomib has been launched in China and is included in medical insurance. Patients can purchase it domestically at a price of around 8,000 to 9,000 yuan. Please consult the local hospital pharmacy for specific prices. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000. And the medicinal ingredients and efficacy are the same as those of domestic original medicines.